Search
Search Results
##search.searchResults.foundPlural##
-
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3514PDF: 1466HTML: 4366CoverLetter: 181Figure1: 192 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1524PDF: 750HTML: 2121Untitled: 214Untitled: 188Untitled: 191Untitled: 193Untitled: 193 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1197PDF: 577HTML: 2851ATRA induced Reactive Hemophagocytosis: A Case Report: 193 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3216PDF: 1065HTML: 425 -
Anemia in the elderly: not always what it seems.
3277PDF: 1015HTML: 1765Figure 1: 170Figure 1 revised: 173 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1748PDF: 680HTML: 2399Untitled: 147Figure 1 a: 152Figure 1 b: 162Fig 1 c: 144Figure 1 d: 190 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1725PDF: 523HTML: 16962Figure 4: 161Figure 3: 135Figure 2: 140Figure 1: 170 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1323PDF: 454HTML: 158 -
DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY
2357PDF: 1099HTML: 2162Untitled: 157 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1157PDF: 820HTML: 3349 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1744PDF: 560HTML: 271 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2297PDF: 976HTML: 7609Untitled: 270Fig2: 180Fig3: 164Fig4: 176 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2395HTML: 9387DOCX: 993Tables Dengue: 203 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1758Suppl. Files: 856HTML: 413PDF: 727 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3294PDF: 714HTML: 704Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 177Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 180Table : Distribution of the sites of bleeding and their causes: 174 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1519PDF: 1183HTML: 175 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3883PDF: 1477HTML: 9179Untitled: 271Untitled: 175Untitled: 162Untitled: 158Untitled: 174Untitled: 331 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1343HTML: 382PDF: 810 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2361PDF: 1571HTML: 607 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3342PDF: 1284HTML: 1854Fig.1: 195Fig. 2: 198 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
809PDF: 536HTML: 4009 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2129PDF: 1452HTML: 258 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1745PDF: 687HTML: 325 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7862PDF: 4071HTML: 7331







